RecruitingPhase 4NCT04567511

Hemlibra in Mild Hemophilia A

Studying Hemophilia A

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Indiana Hemophilia &Thrombosis Center, Inc.
Principal Investigator
Amy D Shapiro, MD
Indiana Hemophilia &Thrombosis Center, Inc.
Intervention
Emicizumab(drug)
Enrollment
20 enrolled
Eligibility
5-45 years · MALE
Timeline
20222027

Study locations (1)

Collaborators

Genentech, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04567511 on ClinicalTrials.gov

Other trials for Hemophilia A

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia A

← Back to all trials